Key Takeaways
- McDonald’s (MCD) beat first-quarter earnings and revenue estimates but missed on global comparable sales, which grew 3.8% against a 3.95% forecast.
- Amazon (AMZN) is aggressively expanding into the GLP-1 market by offering same-day delivery and physical kiosks for the Ozempic pill.
- A "mysterious" $53 billion "Other Income" boost has surfaced in AI hyperscaler earnings, raising questions about the underlying quality of recent tech profits.
- The U.S. labor market is expected to show significant cooling in Friday's report, with economists forecasting only 65,000 new jobs for April.
- Becton Dickinson (BDX) and Kenvue (KVUE) both posted adjusted earnings beats, though KVUE withheld forward guidance amid its pending deal with Kimberly-Clark.
McDonald's and Consumer Health Earnings
McDonald's (MCD) reported a solid start to 2026 with adjusted EPS of $2.83, surpassing the $2.75 analyst consensus. Total revenue reached $6.52 billion, slightly ahead of the $6.46 billion expected. However, the stock faced pressure as global comparable sales of 3.8% fell short of the 3.92% target, signaling potential fatigue in consumer spending.
In the healthcare and consumer sector, Becton Dickinson (BDX) delivered a significant earnings surprise, posting adjusted EPS of $2.90 compared to the $2.18 estimate, despite a revenue miss at $4.1 billion. Meanwhile, Kenvue (KVUE) reported adjusted EPS of $0.32 on sales of $3.91 billion, both beating expectations. The company notably declined to provide forward-looking guidance, citing its ongoing strategic combination with Kimberly-Clark.
Amazon’s Major Healthcare Push
Amazon (AMZN) continues to disrupt the pharmaceutical space by increasing access to the Ozempic pill. The company announced same-day delivery for the medication in nearly 3,000 cities, with plans to reach 4,500 locations by the end of the year.
Additionally, Amazon is deploying new kiosks at select One Medical locations to facilitate immediate pickup. This move positions Amazon as a primary player in the high-demand GLP-1 market, leveraging its logistics network to undercut traditional pharmacy wait times.
The $53 Billion AI Earnings Mystery
A report from the Financial Times has highlighted a massive $53 billion "Other Income" boost appearing on the balance sheets of major AI hyperscalers. This non-operating income has significantly padded recent earnings results, potentially masking the high costs of AI infrastructure buildouts. Analysts are now scrutinizing whether these profits are sustainable or merely the result of one-time investment gains and accounting adjustments.
Macro and Geopolitical Outlook
The market remains on edge ahead of the April Nonfarm Payrolls report, with expectations set at a modest 65,000 jobs. The unemployment rate is projected to hold steady at 4.3%. A weak report could bolster the case for interest rate cuts, while a surprise beat might reignite inflation concerns.
On the geopolitical front, President Biden is scheduled to meet with the President of Brazil today to discuss bilateral trade and environmental policy. Simultaneously, trade official Rollins is reportedly pushing for increased Chinese purchases of U.S. agricultural products, while Ukraine's Rustem Umerov is set to hold high-level talks in Miami with Steve Witkoff and Jared Kushner to discuss the ongoing conflict.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.